Atheroembolic renal disease

The Lancet

Volumn 375, Issue 9726, 2010, Pages 1650-1660

  Scolari, Francesco ^a,b   Ravani, Pietro ^c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SPEDALI CIVILI   (Italy)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; STEROID; WARFARIN;

ACUTE KIDNEY FAILURE; ANTICOAGULANT THERAPY; ARTIFICIAL EMBOLISM; ATHEROEMBOLIC RENAL DISEASE; ATHEROSCLEROTIC PLAQUE; CATHETERIZATION; CLINICAL FEATURE; EOSINOPHILIA; HEART FAILURE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; LABORATORY TEST; LOW DRUG DOSE; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; RENOVASCULAR DISEASE; REVIEW; SKIN DEFECT; SURVIVAL RATE; UREMIA; VASCULAR SURGERY;

EID: 77951879678     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)62073-0     Document Type: Review

References (102)

1. Flory C.M. Arterial occlusions produced by emboli from eroded aortic atheromatous plaques. Am J Pathol 21 (1945) 549-565
2. Thurlbeck W.M., and Castleman B. Atheromatous emboli to the kidneys after aortic surgery. N Engl J Med 257 (1957) 442-447
3. Kassirer J.P. Atheroembolic renal disease. N Engl J Med 280 (1969) 812-818
4. Fine M.J., Kapoor W., and Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology 38 (1987) 769-784
5. Lye W.C., Cheah J.S., and Sinniah R. Renal cholesterol embolic disease. Case report and review of the literature. Am J Nephrol 13 (1993) 489-493
6. Panum P.L. Experimentell Beitrage zur Lehre von der Embolie. Virchows Arch 25 (1862) 308-310
7. Benson R.L. The present status of coronary arterial disease. Arch Pathol Lab Med 2 (1926) 876-916
8. Thadhani R.I., Camargo Jr. C.A., Xavier R.J., Fang L.S., and Bazari H. Atheroembolic renal failure after invasive procedures. Natural history based on 52 histologically proven cases. Medicine 74 (1995) 350-358
9. Mayo R.R., and Swartz R.D. Redefining the incidence of clinically detectable atheroembolism. Am J Med 100 (1996) 524-529
10. Belenfant X., Meyrier A., and Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 33 (1999) 840-850
11. Scolari F., Tardanico R., Zani R., et al. Cholesterol crystal embolism: A recognizable cause of renal disease. Am J Kidney Dis 36 (2000) 1089-1109
12. Scolari F., Ravani P., Pola A., et al. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol 14 (2003) 1584-1590
13. Saklayen M.G. Atheroembolic renal disease: preferential occurrence in whites only. Am J Nephrol 9 (1989) 87-88
14. Cross S. How common is cholesterol embolism?. J Clin Pathol 44 (1991) 859-861
15. Drost H., Buis B., Haan D., and Hillers J.A. Cholesterol embolism as a complication of left heart catheterisation. Report of seven cases. Br Heart J 52 (1984) 339-342
16. Kealy W.F. Atheroembolism. J Clin Pathol 31 (1978) 984-989
17. Moolenaar W., and Lamers C.B. Cholesterol crystal embolization in the Netherlands. Arch Intern Med 156 (1996) 653-657
18. Ramirez G., O'Neill W.M., Lambert R., and Bloomer H.A. Cholesterol embolization: a complication of angiography. Arch Intern Med 138 (1978) 1430-1432
19. Gore I., and Collins D. Spontaneous atheromatous embolization. Review of the literature and a report of 16 additional cases. Am J Clin Pathol 33 (1960) 416-426
20. Jones D.B., and Iannaccone P.M. Atheromatous emboli in renal biopsies. An ultrastructural study. Am J Pathol 78 (1975) 261-276
21. Lie J.T. Cholesterol atheromatous embolism. The great masquerader revisited. Pathol Annu 2 (1992) 17-50
22. Preston R.A., Stemmer C.L., Materson B.J., Perez-Stable E., and Pardo V. Renal biopsy in patients 65 years of age or older. An analysis of the results of 334 biopsies. J Am Geriatr Soc 38 (1990) 669-674
23. Stone W., and Fogo A. Hypertension and renal disease in the elderly (1992), Blackwell, Boston, MA
24. Meyrier A. Cholesterol crystal embolism: diagnosis and treatment. Kidney Int 69 (2006) 1308-1312
25. Modi K., and Rao V. Atheroembolic renal disease. J Am Soc Nephrol 12 (2001) 1781-1787
26. Arroyo L.H., and Lee R.T. Mechanisms of plaque rupture: mechanical and biologic interactions. Cardiovasc Res 41 (1999) 369-375
27. Scolari F., Ravani P., Gaggi R., et al. The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors. Circulation 116 (2007) 298-304
28. Mittal B.V., Alexander M.P., Rennke H.G., and Singh A.K. Atheroembolic renal disease: a silent masquerader. Kidney Int 73 (2008) 126-130
29. Johnson L., Esente P., Giambartolomei A., et al. Peripheral vascular complications of coronary angioplasty by the femoral and brachial techniques. Cathet Cardiovasc Diagn 31 (1994) 165-172
30. Nasser T., Mohler E., Wilensky R., and Hathaway D. Peripheral vascular complications following coronary interventional procedures. Clin Cardiol 18 (1995) 609-614
31. Fukumoto Y., Tsutsui H., Tsuchihashi M., Masumoto A., and Takeshita A. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 42 (2003) 211-216
32. Saklayen M.G., Gupta S., Suryaprasad A., and Azmeh W. Incidence of atheroembolic renal failure after coronary angiography. A prospective study. Angiology 48 (1997) 609-613
33. Rudnick M.R., Berns J.S., Cohen R.M., and Goldfarb S. Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism-a critical review. Am J Kidney Dis 24 (1994) 713-727
34. Feder W., and Auerbach R. "Purple toes": an uncommon sequela of oral coumarin drug therapy. Ann Intern Med 55 (1961) 911-917
35. Moldveen-Geronimus M., and Merriam Jr. J.C. Cholesterol embolization. From pathological curiosity to clinical entity. Circulation 35 (1967) 946-953
36. Hitti W.A., Wali R.K., Weinman E.J., Drachenberg C., and Briglia A. Cholesterol embolization syndrome induced by thrombolytic therapy. Am J Cardiovasc Drugs 8 (2008) 27-34
37. Eliot R.S., Kanjuh V.I., and Edwards J.E. Atheromatous Embolism. Circulation 30 (1964) 611-618
38. Snyder H.E., and Shapiro J.L. A correlative study of atheromatous embolism in human beings and experimental animals. Surgery 49 (1961) 195-204
39. Gore I., McCombs H.L., and Lindquist R.L. Observations on the fate of cholesterol emboli. J Atheroscler Res 4 (1964) 527-535
40. Warren B.A., and Vales O. The ultrastructure of the stages of atheroembolic occlusion of renal arteries. Br J Exp Pathol 54 (1973) 469-478
41. Frock J., Bierman M., Hammeke M., and Reyes A. Atheroembolic renal disease: experience with 22 patients. Nebr Med J 79 (1994) 317-321
42. Zucchelli P., and Zuccalà A. The diagnostic dilemma of hypertensive nephrosclerosis: the nephrologist's view. Am J Kidney Dis 21 (1993) 87-91
43. Falanga V., Fine M.J., and Kapoor W.N. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol 122 (1986) 1194-1198
44. Liew Y.P., and Bartholomew J.R. Atheromatous embolization. Vasc Med 10 (2005) 309-326
45. Donohue K.G., Saap L., and Falanga V. Cholesterol crystal embolization: an atherosclerotic disease with frequent and varied cutaneous manifestations. J Eur Acad Dermatol Venereol 17 (2003) 504-511
46. Jucgla A., Moreso F., Muniesa C., Moreno A., and Vidaller A. Cholesterol embolism: still an unrecognized entity with a high mortality rate. J Am Acad Dermatol 55 (2006) 786-793
47. Ben-Horin S., Bardan E., Barshack I., Zaks N., and Livneh A. Cholesterol crystal embolization to the digestive system: characterization of a common, yet overlooked presentation of atheroembolism. Am J Gastroenterol 98 (2003) 1471-1479
48. Moolenaar W., and Lamers C.B. Cholesterol crystal embolization and the digestive system. Scand J Gastroenterol Suppl 188 (1991) 69-72
49. Moolenaar W., and Lamers C.B. Cholesterol crystal embolisation to the alimentary tract. Gut 38 (1996) 196-200
50. Moolenaar W., and Lamers C. Gastrointestinal blood loss due to cholesterol crystal embolization. J Clin Gastroenterol 21 (1995) 220-223
51. Moolenaar W., and Lamers C. Cholesterol crystal embolization to liver, gallbladder, and pancreas. Dig Dis Sci 41 (1996) 1819-1822
52. Paraf F., Jacquot C., Bloch F., de Montpreville V., and Bruneval P. Cholesterol crystal embolization demonstrated on GI biopsy. Am J Gastroenterol 96 (2001) 3301-3304
53. Beal M., Williams R.S., Richardson Jr. E.P., and Fisher C.M. Cholesterol embolism as a cause of transient ischemic attacks and cerebral infarction. Neurology 31 (1981) 860-865
54. Price D.L., and Harris J. Cholesterol emboli in cerebral arteries as a complication of retrograde aortic perfusion during cardiac surgery. Neurology 20 (1970) 1209-1214
55. Masuda J., Yutani C., Ogata J., Kuriyama Y., and Yamaguchi T. Atheromatous embolism in the brain: a clinicopathologic analysis of 15 autopsy cases. Neurology 44 (1994) 1231-1237
56. Hollenhorst R.W. Significance of bright plaques in the retinal arterioles. JAMA 178 (1961) 23-29
57. Desnuelle C., Lanteri-Minet M., Hofman P., Butori C., Bedoucha P., and Chatel M. Cholesterol emboli with neurologic manifestation in the spinal cord. Rev Neurol 148 (1992) 715-718
58. Reich M.P. Paraplegia following resection of an abdominal aortic aneurysm. Report of a case of atheromatous embolization to the anterior spinal artery. Vasc Surg 2 (1968) 230-234
59. Blankenship J., and Mickel S. Spinal cord infarction resulting from cardiac catheterization. Am J Med 87 (1989) 239-240
60. Slavin R., Gonzalez-Vitale J., and Marin O. Atheromatous emboli to the lumbosacral spinal cord. Stroke 6 (1975) 411-415
61. Robinson R., Pemberton M., and Goddard M.J. Myositis due to cholesterol emboli. Postgrad Med J 69 (1993) 947-949
62. Teja K., and Crampton R.S. Intramural coronary arteritis from cholesterol emboli: a rare cause of unstable angina preceding sudden death. Am Heart J 110 (1985) 168-170
63. Keon W.J., Heggtveit H.A., and Leduc J. Perioperative myocardial infarction caused by atheroembolism. J Thorac Cardiovasc Surg 84 (1982) 849-855
64. Case records of the Massachusetts General Hospital. Weekly Clinicopathological Exercises. Case 11-1996. A 69-year-old man with progressive renal failure and the abrupt onset of dyspnea. N Engl J Med 334 (1996) 973-979
65. Sabatine M., Oelberg D., Mark E.J., and Kanarek D. Pulmonary cholesterol crystal embolization. Chest 112 (1997) 1687-1692
66. Vacher-Coponat H., Pache X., Dussol B., and Berland Y. Pulmonary-renal syndrome responding to corticosteroids: consider cholesterol embolization. Nephrol Dial Transplant 12 (1997) 1977-1979
67. Walton T.J., Samani N.J., and Andrews R. Systemic cholesterol crystal embolisation with pulmonary involvement: a fatal combination after coronary angiography. Postgrad Med J 78 (2002) 288-289
68. Haqqie S., Urizar R., and Singh J. Nephrotic-range proteinuria in renal atheroembolic disease: report of four cases. Am J Kidney Dis 28 (1996) 493-501
69. Greenberg A., Bastacky S., Iqbal A., Borochovitz D., and Johnson J. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations. Am J Kidney Dis 29 (1997) 334-344
70. Kasinath B., Corwin H., Bidani A., Korbet S., Schwartz M., and Lewis E. Eosinophilia in the diagnosis of atheroembolic renal disease. Am J Nephrol 7 (1987) 173-177
71. Cosio F., Zager R., and Sharma H. Atheroembolic renal disease causes hypocomplementaemia. Lancet 2 (1985) 118-121
72. Dahlberg P., Frecentese D., and Cogbill T. Cholesterol embolism: experience with 22 histologically proven cases. Surgery 105 (1989) 737-746
73. Scoble J.E., and O'Donnell P.J. Renal atheroembolic disease: the Cinderella of nephrology?. Nephrol Dial Transplant 11 (1996) 1516-1517
74. Smyth J.S., and Scoble J.E. Atheroembolism. Curr Treat Options Cardiovasc Med 4 (2002) 255-265
75. Anderson W.R., and Richards A.M. Evaluation of lower extremity muscle biopsies in the diagnosis of atheroembolism. Arch Pathol 86 (1968) 535-541
76. Ripple M., Charney D., and Nadasdy T. Cholesterol embolization in renal allografts. Transplantation 69 (2000) 2221-2225
77. Lai C., and Randhawa P. Cholesterol embolization in renal allografts: a clinicopathologic study of 12 cases. Am J Surg Pathol 31 (2007) 536-545
78. de Takats D., Pollock L., O'Donnell P., Snowden S., Bewick M., and Scoble J.E. Is cholesterol embolic disease an unrecognized cause of renal graft dysfunction?. Nephrol Dial Transplant 11 (1996) 1325-1327
79. Jennings W., Smith J., and Corry R. Atheromatous embolization as a cause of increasing creatinine levels in a renal transplant patient. Transplant Proc 22 (1990) 279
80. Scolari F., Tardanico R., Pola A., et al. Cholesterol crystal embolic disease in renal allografts. J Nephrol 16 (2003) 139-143
81. Shappell H., Nylander W., VanBuren D., and Fogo A. Adult man with primary allograft nonfunction. Am J Kidney Dis 35 (2000) 997-1001
82. Singh I., Killen P., and Leichtman A. Cholesterol emboli presenting as acute allograft dysfunction after renal transplantation. J Am Soc Nephrol 6 (1995) 165-170
83. Ackoundou-N'Guessan C., Bismuth J., Canet S., Iborra F., and Mourad G. Partial recovery of delayed graft function due to cholesterol emboli after renal transplantation. Saudi J Kidney Dis Transpl 19 (2008) 631-635
84. Schonermarck U., Guba M., Weiss M., Illner W.D., Arbogast H., and Bosch T. Cholesterol atheroembolic disease in kidney allografts-case report and review of the literature. Clin Nephrol 66 (2006) 386-390
85. Ott U., Gerth J., Grone H.J., Grone E., and Wolf G. Cholesterol embolization in a renal graft. Clin Transplant 22 (2008) 677-680
86. Siemons L., van den Heuvel P., Parizel G., Buyssens N., De Broe M., and Cuykens J. Peritoneal dialysis in acute renal failure due to cholesterol embolization: two cases of recovery of renal function and extended survival. Clin Nephrol 28 (1987) 205-208
87. Theriault J., Agharazzi M., Dumont M., Pichette V., Ouimet D., and Leblanc M. Atheroembolic renal failure requiring dialysis: potential for renal recovery? A review of 43 cases. Nephron Clin Pract 94 (2003) 11-18
88. Yucel A., Kart-Koseoglu H., Demirhan B., and Ozdemir F. Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases. Rheumatol Int 26 (2006) 454-460
89. Nakayama M., Nagata M., Hirano T., et al. Low-dose prednisolone ameliorates acute renal failure caused by cholesterol crystal embolism. Clin Nephrol 66 (2006) 232-239
90. Mann S., and Sos T.A. Treatment of atheroembolization with corticosteroids. Am J Hypertens 14 (2001) 831-834
91. Woolfson R.G., and Lachmann H. Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet 351 (1998) 1331-1332
92. Keen R., McCarthy W., Shireman P., et al. Surgical management of atheroembolization. J Vasc Surg 21 (1995) 773-780
93. Matchett W., McFarland D., Eidt J., and Moursi M. Blue toe syndrome: treatment with intra-arterial stents and review of therapies. J Vasc Interv Radiol 11 (2000) 585-592
94. Carroccio A., Olin J.W., Ellozy S.H., et al. The role of aortic stent grafting in the treatment of atheromatous embolization syndrome: results after a mean of 15 months follow-up. J Vasc Surg 40 (2004) 424-429
95. Rocha-Singh K.J., Eisenhauer A.C., Textor S.C., et al. Atherosclerotic peripheral vascular disease symposium II: intervention for renal artery disease. Circulation 118 (2008) 2873-2878
96. Polu K.R., and Wolf M. Clinical problem-solving. Needle in a haystack. N Engl J Med 354 (2006) 68-73
97. Scoble J.E. Is nihilism in the treatment of atheroembolic disease at an end?. Am J Kidney Dis 33 (1999) 975-976
98. Cogan E., Schandene L., Papadopoulos T., Crusiaux A., and Goldman M. Interleukin-5 production by T lymphocytes in atheroembolic disease with hypereosinophilia. J Allergy Clin Immunol 96 (1995) 427-429
99. LaRosa J., Grundy S., Waters D., et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352 (2005) 1425-1435
100. Pedersen T.R., Faergeman O., Kastelein J.J., et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomised controlled trial. JAMA 294 (2005) 2437-2445
101. Reimers B., Corvaja N., Moshiri S., et al. Cerebral protection with filter devices during carotid artery stenting. Circulation 104 (2001) 12-15
102. Henry M., Henry I., Klonaris C., et al. Renal angioplasty and stenting under protection: the way for the future?. Catheter Cardiovasc Interv 60 (2003) 299-312